Latest / Becker’s Healthcare Podcast / Scott Becker - 12 Innovations in Healthcare 5-11-26

Transcript

Scott Becker - 12 Innovations in Healthcare 5-11-26 · Becker’s Healthcare Podcast

• 0:00
  This is Scott Becker with the Becker's Healthcare
• 0:03
  podcast.
• 0:04
  Today's discussion
• 0:06
  is about 12 health care innovations,
• 0:09
  and and I love your feedback on this
• 0:11
  as well. This is Scott Becker, the publisher
• 0:13
  and founder of Becker's Healthcare.
• 0:16
  My text number is (773)
• 0:19
  766-5322.
• 0:21
  And if you're the first person to give
• 0:23
  me feedback on this podcast, not just call
• 0:26
  me, not just text me, but text me
• 0:28
  with some feedback on it. Was the sound
• 0:29
  quality okay? Did I talk at the right
• 0:31
  pace? Was it interesting? We'll send you a
• 0:34
  $100
• 0:35
  Amazon gift certificate for myself or Becker's Healthcare.
• 0:38
  Thank you for listening. Again, that number, (773)
• 0:42
  766-5322.
• 0:44
  So so often we talk about the challenges
• 0:47
  in health care, supply and demand,
• 0:49
  trends that seem to be walking against us,
• 0:51
  working against us,
• 0:53
  the challenges in the triple aim of cost,
• 0:56
  access, and quality all sort of going in
• 0:59
  the wrong direction. Today's discussion is gonna be
• 1:01
  a counter to that.
• 1:02
  We're gonna talk about 12 of the things
• 1:04
  in health or the innovations
• 1:06
  that seem to be moving things in the
• 1:08
  right direction.
• 1:10
  And we see a lot of these. We
• 1:11
  see a lot of positivity to go with
• 1:13
  a lot of negativity.
• 1:14
  So the first is
• 1:16
  artificial intelligence and the impact in certain areas,
• 1:19
  like ambient listening, logistics,
• 1:23
  predictive analytics,
• 1:24
  revenue cycle, it's evolving,
• 1:26
  supply chain, virtual nursing, and more and more
• 1:29
  progress on clinical.
• 1:31
  It's not that AI is a total game
• 1:33
  changer today, but you could clearly see it
• 1:35
  making big inroads and big positives
• 1:38
  in a lot of ways. And I think
• 1:39
  you'll see it also be a huge supplement
• 1:41
  in primary care with PAs and Ps and
• 1:44
  primary care physicians as well where we are
• 1:47
  willfully short and have been willfully short.
• 1:50
  The second big innovation, and it follows from
• 1:53
  that,
• 1:54
  movement of care from doctors in some areas
• 1:57
  to PAs and Ps and allied health professionals,
• 2:00
  also, overall
• 2:02
  workflow redesign that we're seeing.
• 2:05
  The third is the emergence of GLP ones
• 2:08
  at scale, and this is fascinating in so
• 2:09
  many different ways. And I'll talk about it.
• 2:12
  Fourth, the other way that's fascinating. The first
• 2:14
  thing is the amount of people that GLP
• 2:16
  ones have become accessible to, simply remarkable how
• 2:20
  many people are using GLP ones and how
• 2:22
  well that's going and moving things in the
• 2:24
  right direction. Imperfect,
• 2:26
  hopefully, doesn't cause massive sorts of problems of
• 2:29
  different types,
• 2:30
  but just the the the movement of so
• 2:32
  many people cutting their weight. Some
• 2:34
  is so good for so many aspects of
• 2:36
  health. So we're watching this evolution and the
• 2:38
  growth at scale. We're also seeing the free
• 2:40
  enterprise system work well
• 2:42
  as the price of these keeps on coming
• 2:44
  down and different ways to get them keep
• 2:46
  on coming down. I think just overall, a
• 2:48
  fantastic
• 2:49
  case study in in real,
• 2:51
  really, population health driven by sort of, you
• 2:54
  know, capitalist economy
• 2:56
  and and free enterprise.
• 2:58
  Fourth,
• 2:59
  the increasing
• 3:00
  movement of traditional care
• 3:02
  out of traditional health systems and clinics.
• 3:05
  This is so important because it takes some
• 3:07
  some of the stress of health systems
• 3:10
  that are needed more and more to deal
• 3:12
  with this aging and growing population
• 3:14
  and more acute and chronic problems in deeper
• 3:17
  and more complex things. So even you take,
• 3:20
  for example, the GLP ones I talked about
• 3:21
  a moment ago,
• 3:23
  now tens of millions of people are in
• 3:24
  GLP ones.
• 3:26
  In the old days, so much of that
• 3:28
  was done ultimately through, you know, going to
• 3:30
  the doctor's office, talking to the doctor, the
• 3:32
  traditional health system.
• 3:34
  Now a huge amount of of that is
• 3:35
  being done by the telehealth companies of the
• 3:38
  world, whether it's the Rose Sparks, the Hims
• 3:40
  and Hers, so many others. But I can't
• 3:42
  even imagine how much that would clog up
• 3:44
  the system if not being done in this
• 3:46
  other way.
• 3:48
  The fifth thing that we're watching,
• 3:50
  is the evolutions
• 3:52
  of vaccines and immunotherapies
• 3:53
  for cancers.
• 3:55
  I'm amazed at how this has come along.
• 3:57
  It's still a work in process,
• 3:59
  but such an important development for still one
• 4:01
  of our two largest killers,
• 4:04
  cardiology and and oncology,
• 4:06
  cancer and heart disease.
• 4:08
  Amazing movement of vaccines and immunotherapy
• 4:11
  in that area.
• 4:13
  Sixth, the movement to minimally invasive surgery.
• 4:16
  This, again, has made recovery and outcomes so
• 4:19
  much better and led to so much less
• 4:21
  infections,
• 4:22
  so much shorter hospital stays, and such a
• 4:24
  huge positive over the last decade.
• 4:27
  The seventh thing I'll talk about is the
• 4:28
  movement to precision medicine. Again,
• 4:32
  in precision medicine,
• 4:34
  now more than ever, you could you could
• 4:35
  really dial for some genomics with a drug
• 4:38
  to see if it will work or not
• 4:39
  work and move back to sort of not
• 4:41
  having to do so much trial and error
• 4:43
  because you could more quickly and clearly tailor
• 4:46
  the right drug, the right biologics to the
• 4:48
  right person and their makeup. And what you've
• 4:50
  seen with precision medicine is there's so much
• 4:53
  differences out here as to what works and
• 4:55
  doesn't work for different people based on their
• 4:57
  own genomic structure, their own DNA, and so
• 4:59
  forth.
• 5:01
  Eighth, the acceleration in training of nurses over
• 5:04
  the last couple of years,
• 5:06
  towards the end of COVID and onward has
• 5:08
  been nothing short of remarkable.
• 5:10
  We're now turning it out into our country,
• 5:12
  a 190
• 5:13
  to 230,000
• 5:15
  nurses a year.
• 5:16
  This is incredible
• 5:18
  how quickly we've moved to sort of improve
• 5:21
  the supply of nurses. Doctors were doing horrible,
• 5:24
  but our nurses would make tremendous, tremendous strides.
• 5:27
  It's simply remarkable.
• 5:29
  Ninth, and this causes some challenges as well,
• 5:31
  but overall a great thing,
• 5:34
  the accelerated screenings for cancers
• 5:37
  mean that more and more people are finding
• 5:38
  and able to treat
• 5:40
  pre cancer situations and cancer earlier and earlier.
• 5:43
  Of course, we don't have the systems yet
• 5:45
  to take care of all those people, but
• 5:46
  but this is a real movement in the
• 5:48
  right direction,
• 5:49
  the accelerated screening for cancers and the potential
• 5:52
  lives saved by that. Tenth, the movement of
• 5:55
  health systems
• 5:56
  back to
• 5:57
  focusing so extensively
• 5:59
  on cardiology,
• 6:00
  on college and orthopedics,
• 6:02
  where there's both big need and big money.
• 6:05
  So when you go to a hospital campus
• 6:07
  today, the thing most likely being built is
• 6:09
  something for oncology, orthopedics,
• 6:11
  or heart disease,
• 6:12
  and there's a lot of rhyme and reason
• 6:14
  there. Those are the most
• 6:16
  prevalent challenges,
• 6:18
  and there's also money there. So it so
• 6:19
  it seems to work.
• 6:21
  Eleventh,
• 6:22
  I love the development going on by Mark
• 6:25
  Cuban at Cost Plus Drugs and Civica,
• 6:28
  the the put together by not from its
• 6:30
  systems to to try and solve drug cost,
• 6:32
  generics, and more. I love both those efforts.
• 6:35
  Finally, 12. Another thing that we're watching is
• 6:38
  the evolution of wearables and the use there,
• 6:41
  and I think that's also a fantastic development
• 6:43
  is the the use and improvement of wearables
• 6:46
  and how well they scan what's going on
• 6:48
  with the patient.
• 6:49
  Thank you so much for listening to this
• 6:51
  version of the Becker's Healthcare podcast, and thank
• 6:53
  you to our wonderful producer, Chanel Banger.
• 6:56
  Again, I know my thoughts are always imperfect.
• 6:59
  If you're the first person to share with
• 7:01
  me by text, (773)
• 7:03
  766-5322,
• 7:05
  your thoughts on this, I'll send you a
• 7:07
  $100 Amazon gift certificate. Again, thank you for
• 7:10
  listening to the Becker's Healthcare podcast.